Human MCF-7 breast cancer cells were treated with survivin-siRNA and conjugates also containing nanoparticles (NDCONH (CH2) 2NH-VDGR/survivin-siRNA) and grown for 48 h. Here, BIRC5 is linked to breast cancer.